menu
    • menu

    Company profile for Linnaeus Therapeutics

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-12-22

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Linnaeus Therapeutics is a development stage biotech company engaged in the identification and development of small molecule agents for the treatment of cancer. Linnaeus is a Penn Center for Innovation UPstart company that was founded in 2016. Linnaeus is based upon discoveries from the Ridky lab at the University of Pennsylvania. We are developing our initial therapies that are supported by a foundation of clinical experience...
    Linnaeus Therapeutics is a development stage biotech company engaged in the identification and development of small molecule agents for the treatment of cancer. Linnaeus is a Penn Center for Innovation UPstart company that was founded in 2016. Linnaeus is based upon discoveries from the Ridky lab at the University of Pennsylvania. We are developing our initial therapies that are supported by a foundation of clinical experience. We believe that if you observe the clinical experience and listen to what it tells us, it will lead to the identification of new therapeutic targets for cancer.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Linnaeus TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    30 Washington Ave Suite F Haddonfield, NJ 08033
    Telephone
    Telephone
    856.433.1300
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://linnaeustx.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Linnaeus Therapeutics Wins Fourth SBIR Award from NCI, Total Fund
    Linnaeus Therapeutics Wins Fourth SBIR Award from NCI, Total Fund

    26 Mar 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/linnaeus-therapeutics-awarded-its-fourth-competitive-sbir-award-by-the-national-cancer-institute-bringing-total-sbir-funding-to-8-3-million-302412016.html

    PR NEWSWIRE
    26 Mar 2025
    Share Share
    Linnaeus Therapeutics Publishes Paper on LNS8801 in Cancer Researh
    Linnaeus Therapeutics Publishes Paper on LNS8801 in Cancer Researh

    20 Mar 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/linnaeus-therapeutics-announces-publication-of-seminal-paper-on-lns8801-in-cancer-research-communications-302406094.html

    PR NEWSWIRE
    20 Mar 2025
    Share Share
    Linnaeus Reports Positive LNS8801 Data In Metastatic Melanoma
    Linnaeus Reports Positive LNS8801 Data In Metastatic Melanoma

    16 Sep 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/linnaeus-therapeutics-announces-presentation-of-positive-clinical-data-of-lns8801-in-metastatic-melanoma-at-2024-esmo-annual-meeting-302249003.html

    PR NEWSWIRE
    16 Sep 2024
    Share Share
    Linnaeus Announces Issuance of Composition of Matter Patent by the EPO
    Linnaeus Announces Issuance of Composition of Matter Patent by the EPO

    02 Apr 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/linnaeus-therapeutics-announces-issuance-of-composition-of-matter-patent-for-lns8801-by-the-european-patent-office-302105941.html

    PR NEWSWIRE
    02 Apr 2024
    Share Share
    Linnaeus Announces Presentation of Positive Clinical Data of LNS8801
    Linnaeus Announces Presentation of Positive Clinical Data of LNS8801

    06 Jun 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/linnaeus-therapeutics-announces-presentation-of-positive-clinical-data-of-lns8801-in-metastatic-uveal-melanoma-at-2023-asco-annual-meeting-301843582.html

    PR NEWSWIRE
    06 Jun 2023
    Share Share
    Linnaeus Granted ODD for LNS8801 for Metastatic Cutaneous Melanoma
    Linnaeus Granted ODD for LNS8801 for Metastatic Cutaneous Melanoma

    19 Jan 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/linnaeus-therapeutics-granted-orphan-drug-designation-for-lns8801-for-the-treatment-of-patients-with-metastatic-cutaneous-melanoma-301725268.html

    PR NEWSWIRE
    19 Jan 2023
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search